https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Immunology

The immunology drugs market size is growing steadily and with biosimilars already beginning to affect the market it will become more active. As the population ages and more people are looking for effective drugs for a host of maladies, the scope of immunology drugs market research is expanding at a significant rate.

Click Here to Learn About Our Global Capabilities in Immunology Drugs Market Research

Markets included within immunology drugs includes: Crohn’s Disease Drug Market, Rheumatoid Arthritis Drug Market, Psoriasis Drug Market, Ulcerative Colitis Drug Market, and the Ankylosing Spondylitis Drug Market. iData Research has done extensive immunology drugs market analysis to give you access to important and accurate market trends. Our reports let you know exactly where you should direct your efforts.

Showing all 5 results

Ulcerative Colitis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat ulcerative colitis across the globe (12 countries), including Entyvio, Humira, Remicade, and Simponi. The ulcerative colitis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Psoriasis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat psoriasis across the globe (12 countries), including Humira, Enbrel, Remicade, and Stelera. The psoriasis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Rheumatoid Arthritis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat rheumatoid arthritis across the globe (12 countries), including Orencia, Humira, Cimzia, Enbrel, Simponi, Remicade, Rituxan, Actemra, and Xeljanz. The rheumatoid arthritis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Ankylosing Spondylitis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat ankylosing spondylitis across the globe (12 countries), including Humira, Cimzia, Enbrel, Simponi, and Remicade. The ankylosing spondylitis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Crohn’s Disease Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat Crohn's disease across the globe (12 countries), including Humira, Cimzia, Remicade, Stelara, Entyvio, and Tysabri. The Crohn's disease drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...